232 related articles for article (PubMed ID: 17653062)
1. Lipodystrophy in HIV 1-infected patients: lessons for obesity research.
Villarroya F; Domingo P; Giralt M
Int J Obes (Lond); 2007 Dec; 31(12):1763-76. PubMed ID: 17653062
[TBL] [Abstract][Full Text] [Related]
2. Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.
Villarroya F; Domingo P; Giralt M
Trends Pharmacol Sci; 2005 Feb; 26(2):88-93. PubMed ID: 15681026
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
Guallar JP; Gallego-Escuredo JM; Domingo JC; Alegre M; Fontdevila J; Martínez E; Hammond EL; Domingo P; Giralt M; Villarroya F
AIDS; 2008 Mar; 22(5):575-84. PubMed ID: 18316998
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
[TBL] [Abstract][Full Text] [Related]
5. Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes--relevance for partial lipodystrophy.
Kovsan J; Osnis A; Maissel A; Mazor L; Tarnovscki T; Hollander L; Ovadia S; Meier B; Klein J; Bashan N; Rudich A
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E315-22. PubMed ID: 19033543
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
[TBL] [Abstract][Full Text] [Related]
7. HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo.
Lagathu C; Kim M; Maachi M; Vigouroux C; Cervera P; Capeau J; Caron M; Bastard JP
Biochimie; 2005 Jan; 87(1):65-71. PubMed ID: 15733739
[TBL] [Abstract][Full Text] [Related]
8. A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
Kim MJ; Leclercq P; Lanoy E; Cervera P; Antuna-Puente B; Maachi M; Dorofeev E; Slama L; Valantin MA; Costagliola D; Lombes A; Bastard JP; Capeau J
Antivir Ther; 2007; 12(8):1273-83. PubMed ID: 18240867
[TBL] [Abstract][Full Text] [Related]
9. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
Gougeon ML; Pénicaud L; Fromenty B; Leclercq P; Viard JP; Capeau J
Antivir Ther; 2004 Apr; 9(2):161-77. PubMed ID: 15134178
[TBL] [Abstract][Full Text] [Related]
10. [Lipodystrophies related to antiretroviral treatment of HIV infection].
Capeau J; Caron M; Vigouroux C; Cervera P; Kim M; Maachi M; Lagathu C; Bastard JP
Med Sci (Paris); 2006 May; 22(5):531-6. PubMed ID: 16687123
[TBL] [Abstract][Full Text] [Related]
11. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
Leclercq P; Blanc M
Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.
Casula M; van der Valk M; Wit FW; Nievaard MA; Reiss P
HIV Med; 2007 Jan; 8(1):32-7. PubMed ID: 17305930
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue biology and HIV-infection.
Giralt M; Domingo P; Villarroya F
Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):487-99. PubMed ID: 21663842
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals.
Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM
Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709
[TBL] [Abstract][Full Text] [Related]
16. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy.
Lloreta J; Domingo P; Pujol RM; Arroyo JA; Baixeras N; Matias-Guiu X; Gilaberte M; Sambeat MA; Serrano S
Virchows Arch; 2002 Dec; 441(6):599-604. PubMed ID: 12461618
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of antiretroviral-induced mitochondrial dysfunction in adipocytes and adipose tissue: in-vitro, animal and human adipose tissue studies.
Villarroya F; Domingo P; Giralt M
Curr Opin HIV AIDS; 2007 Jul; 2(4):261-7. PubMed ID: 19372897
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria and HIV infection: the first decade.
Cossarizza A; Troiano L; Mussini C
J Biol Regul Homeost Agents; 2002; 16(1):18-24. PubMed ID: 12003168
[TBL] [Abstract][Full Text] [Related]
20. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
